HistoIndex, a global leading artificial intelligence digital pathology (AI-DP) provider, announced that its AI-based qFibrosis, qSteatosis and qBallooning algorithms delivered sensitivity and granularity on...
Ortho Regenerative Technologies Inc., a clinical-stage orthobiologics company focused on the development of novel soft tissue repair regenerative technologies, today announced the initiation of...
The DeepCT is the world's leading AI-driven system developed by Deep01 to identify abnormal CT scan images. Recently, Kaohsiung Veterans General Hospital (KVGH), the...
Antengene Corporation Limited, a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and oncology,...
Moleculin Biotech, Inc., a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, reported preliminary results...
